Howard C. Herrmann, MD
Howard C. Herrmann, MD, is the John W. Bryfogle Professor of Medicine and Surgery at the Perelman School of Medicine and Health System Director for Interventional Cardiology and Director of the Cardiac Catheterization Laboratories at the Hospital of the University of Pennsylvania, Philadelphia. In addition to being an active practicing cardiologist, Dr. Herrmann is an active investigator on many important clinical trials. His current research interest focuses primarily on new device therapies for valvular and structural heart disease. He is a past President of the Pennsylvania Chapter of the American College of Cardiology and recently received the Master Designation of the Society for Cardiac Angiography and Intervention. He has been writing for NEJM Journal Watch Cardiology since the publication’s launch in 1995 and was Deputy Editor from 2006 to 2015.
Leerink Swann; Wells Fargo; Edwards Lifesciences; BMO Capital Markets
Micro Interventional Devices, Inc.
Abbott Vascular; Bayer; Boston Scientific; Corvia; Edwards Lifesciences; St. Jude Medical; Medtronic; Cardiokinetix; University of Laval
Catheterization and Cardiovascular Interventions; Circulation: Cardiovascular Interventions; Journal of Interventional Cardiology; Journal of Invasive Cardiology; Journal of the American College of Cardiology
- August 29, 2007
- November 14, 2007
- September 19, 2007
- June 27, 2007
- December 12, 2007
- June 13, 2007